期刊文献+

安钠咖滥用者的胰腺分泌和C肽及肿瘤坏死因子变化 被引量:2

ALTERATION IN PANCREAS SECRETION,C PEPTIDE AND TUMOR NECROSIS FACTOR OF LONG TIME CAFFEINE SODIUM BENZOATE USE
下载PDF
导出
摘要 目的:观察安钠咖滥用者的胰腺分泌和C肽及肿瘤坏死因子变化。方法:应用电化学发光免疫分析法测定36例安钠咖滥用者与14例正常对照血中胰岛素、C肽及肿瘤坏死因子量。结果:安钠咖滥用组与正常对照组比较胰岛素、C肽明显增高(P<0.05),肿瘤坏死因子增高,但在统计学上无差异(P>0.05)。结论:安钠咖滥用者的胰腺分泌和C肽及肿瘤坏死因子升高。 Objective:To observe the alteration in pancreas secretion,C peptide and tumor necrosis factor of long time caffeine sodium benzoate use.Methods:Serum insulin,C peptide and tumor necrosis factor of 36 long time caffeine sodium benzoate users and 14 normal control group were determined by electro-chemistry immunity analytical method.Results:Significant difference was observed in the serum insulin,C peptide of the caffeine sodium benzoate users and the control(P〈0.05).Rise of tumor necrosis factor was also found in the users but did not show significant difference compared with the control(P〉0.05).Conclusion:Long time caffeine sodium benzoate use would lead to the rise of pancreas secretion,C peptide and tumor necrosis factor of the users.
出处 《中国药物依赖性杂志》 CAS CSCD 2008年第2期138-139,共2页 Chinese Journal of Drug Dependence
基金 内蒙古卫生科技项目资助(课题编号:2006092)
关键词 安钠咖滥用者 胰岛素 C肽 肿瘤坏死因子 caffeine sodium benzoate user insulin C peptide tumor necrosis factor
  • 相关文献

参考文献7

二级参考文献27

  • 1曾天舒,陈璐璐,袁莉.吡格列酮减轻肿瘤坏死因子α所致3T3-L1脂肪细胞胰岛素抵抗[J].中华糖尿病杂志(1006-6187),2005,13(6):423-425. 被引量:5
  • 2辛淮生,陆任云.咖啡因对实验小鼠的致衰老作用[J].镇江医学院学报,1996,6(4):315-316. 被引量:4
  • 3李密 见李密 刘志民 赵冬编著.苯丙胺类、可卡因和其它兴奋剂[A].见李密,刘志民,赵冬编著.药物滥用与药物依赖性[C].北京:中国科学技术出版社,1992.250~279.
  • 4.咖啡因管理规定[A].见卫生部药政管理局编.精神药品手册(修订版)[C].,1991.25~31.
  • 5[2]Owens DR, Zinmau B, Bolli GB. Insulin today and beyond. Lancet 2001; 358: 739
  • 6[3]Barnett AH, Owens DR. Insulin analogues. Lancet. 1997; 349:47
  • 7[4]Home P, Lindholm A, RiisA. European Insulin Aspart study Group, Insulin aspart vs human insulin in the management of long-term blood glucose control in type 1 diabetes mellitus : a randomized controlled trial. Diabetic Med. 2000; 17:762
  • 8[5]Raskin P, Guthrie R, Leiter L, et al. Use of insulin aspart, a fast- acting insulin analog, as the meattime insulin in the management of patients with type 1 diabetes. Diabetes Care. 2000; 23: 583
  • 9[6]Tamas G, Marre M, Astorga R, et al. Glycaemic control in type 1diabetic patients using optimized insulin aspart or human insulin in a randomized mutinational study. Diabetes Res Clin Pract .2001; 54:105
  • 10[7]Galloway JA, Frank BH Hooper SA, et al. Biosynthetic human proinsulin. Diabetes Care、 1992; 15:666

共引文献16

同被引文献26

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部